Skip to main content

Humana Value Stock - Dividend - Research Selection

Humana

ISIN: US4448591028 , WKN: 856584

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


New Survey Offers Important Insights into How Medicare Advantage Beneficiaries Use and Value Their Supplemental Benefits

2025-11-20
LOUISVILLE, Ky., November 20, 2025--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

2025-11-20
HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total pol

U.S. Managed Care Q3 2025 Earnings Recap: Costs Grow As ACA Worries Loom

2025-11-20
US managed care insurers' Q3 earnings season was characterized by higher medical costs amid political uncertainty surrounding extensions of the Affordable Care Act tax credits.

New Research from the Humana Foundation Examines Food Insecurity Crisis Among Kentucky Seniors

2025-11-19
LOUISVILLE, Ky., November 19, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in Kentucky: A Growing Public Health Challenge. The brief examines the complex web of challenges the state’s older adults face in accessing nutritious foods and offers a call to action with recommended investments that can help overcome those barriers.

Should You Invest in Humana (HUM)?

2025-11-19
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities rallied in the third quarter, driven by AI enthusiasm, resilient corporate earnings, the first U.S. rate cut of the year, and targeted policy easing across key regions. Against this […]

Humana Inc. (HUM) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

2025-11-19
Humana Inc. (HUM) 7th Annual Wolfe Research Healthcare Conference November 19, 2025 8:40 AM ESTCompany ParticipantsCeleste Mellet - Chief Financial...

IHF: Healthcare Dashboard For November

2025-11-19
Healthcare providers are undervalued. Click here to find out which stocks are the cheapest and if the IHF ETF is a risky buy.

What Humana (HUM)'s Profit Drop and Lowered Outlook Mean For Shareholders

2025-11-19
In early November 2025, Humana Inc. reported third quarter results showing increased revenue to US$32.65 billion, but net income dropped to US$195 million compared to the previous year. The company also completed a US$200 million share buyback and revised its 2025 annual earnings guidance downward to approximately US$12.26 per share. One standout detail is that while revenue continued to rise both in the quarter and year-to-date, Humana’s profitability faced headwinds, leading to a sizable...

CenterWell Home Health Branches Collect 287,000 Meals for Needy

2025-11-18
LOUISVILLE, Ky., November 18, 2025--CenterWell Home Health branches collect 287,000 meals for needy.

Less Paperwork, More Connected Care: Humana and Epic Advance Data Sharing

2025-11-18
LOUISVILLE, Ky., November 18, 2025--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.